FindTrial
Sign In

A phase 2b study of M110101 in seborrheic dermatitis patients

A phase 2b study of M110101 in seborrheic dermatitis patients

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221910
Enrollment
Unknown
Registered
2012-09-06
Start date
2012-09-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seborrheic dermatitis

Interventions

investigational material(s) Generic name etc : M110101 INN of investigational material : Therapeutic category code : 264 Analgesics, anti-itchings, astrigents and anti-inflammatory agents Dosage and

Sponsors

Maruho Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with sebborrheic dermatitis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
change of total score in skin symptom—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026